Combination Therapy For Treatment Of B-Cell Malignancies | Patent Publication Number 20200262925
US 20200262925 A1Publication DateAug 20, 2020
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsSriram Balasubramanian
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.